Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Pipeline Therapeutics to Participate in the Stifel 2019 Healthcare Conference


Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, today announced that the company will participate in the Stifel 2019 Healthcare Conference taking place November 19-21, 2019, in New York, NY.

President and Chief Executive Officer Carmine Stengone is scheduled to present on Wednesday, November 20 at 2:25 p.m. ET.

About Pipeline Therapeutics

Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, including synaptogenesis, remyelination and axonal repair. The company's lead product candidate, PIPE-505, is a small molecule gamma secretase inhibitor (GSI) to treat mild-to-moderate sensorineural hearing loss (SNHL) associated with cochlear synaptopathy. A Phase 1b/2a study of PIPE-505 in SNHL is expected to begin enrolling patients in 4Q 2019, with topline results expected in late 2020. The company also has a portfolio of earlier stage programs, including PIPE-307, focused on remeylation and axonal repair, to address a range of neurological disorders, including multiple sclerosis. For more information, please visit www.pipelinetherapeutics.com.


These press releases may also interest you

at 09:05
Community Care Cooperative (C3), the Accountable Care Organization (ACO) that advances community-based care for MassHealth members through its network of 19 health centers throughout the state, today announced the launch of a $5 million campaign to...

at 09:05
NS1, the leader in modern application networking, today announced its compelling lineup of speakers for INS1GHTS2020, a free, interactive digital gathering of industry leaders in NetOps, DevOps, and application delivery. From 6:30 a.m. to 7 p.m. EDT...

at 09:05
Genesis, an industry pioneer and leader in digital currency trading and lending, today announced it has launched a derivatives trading desk. The new offering, which follows last week's announcement that Genesis is launching a prime brokerage service...

at 09:05
Guided Therapeutics, Inc. (Pink Sheets: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced that it had completed software changes and documentation required by the Chinese FDA for...

at 09:05
Kronos: What: Joyce Maroney, executive director of The Workforce Institute at Kronos Incorporated, welcomes Andrew Barnes, founder of New Zealand estate planning company Perpetual Guardian, and Charlotte Lockhart, CEO of 4 Day Week Global....

at 09:05
Aptum, a global hybrid cloud and managed services provider, today launched its Managed DevOps Service in partnership with CloudOps, a cloud consulting and professional services company specializing in DevOps. The Managed DevOps Service offers a...



News published on 13 november 2019 at 16:10 and distributed by: